Aspartoacylase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 14: Line 14:
<scene name='49/498146/Cv/4'>Catalytic site</scene> of human aspartocyclase with <scene name='49/498146/Cv/5'>aspartate analogue and Zn+2</scene> ([[2o4h]]).<ref>PMID:18293939</ref>
<scene name='49/498146/Cv/4'>Catalytic site</scene> of human aspartocyclase with <scene name='49/498146/Cv/5'>aspartate analogue and Zn+2</scene> ([[2o4h]]).<ref>PMID:18293939</ref>
-
</StructureSection>
+
 
-
__NOTOC__
+
==3D structures of aspartoacylase==
 +
[[Aspartoacylase 3D structures]]
 +
 
==GO Annotation==
==GO Annotation==
{| class="wikitable"
{| class="wikitable"
Line 275: Line 277:
}}
}}
-
 
+
</StructureSection>
==References==
==References==

Revision as of 08:27, 25 March 2019

Human aspartocyclase dimer complex with aspartate analogue and Zn+2 (grey) 2o4h

Drag the structure with the mouse to rotate

References

  1. http://www.uniprot.org/uniprot/Q9R1T5
  2. Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN Jr. Structure of aspartoacylase, the brain enzyme impaired in Canavan disease. Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):456-61. Epub 2006 Dec 28. PMID:17194761
  3. Le Coq J, Pavlovsky A, Malik R, Sanishvili R, Xu C, Viola RE. Examination of the Mechanism of Human Brain Aspartoacylase through the Binding of an Intermediate Analogue(,). Biochemistry. 2008 Mar 18;47(11):3484-92. Epub 2008 Feb 23. PMID:18293939 doi:10.1021/bi702400x
  4. http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9R1T5

Additional Literature and Resources

  • Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN Jr. Structure of aspartoacylase, the brain enzyme impaired in Canavan disease. Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):456-61. Epub 2006 Dec 28. PMID:17194761

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky

Personal tools